Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyroid function before and after roxadustat or erythropoietin treatment in renal anemia
ChiCTR2100054190Phase 4Recruiting
- Sponsor
- Shenzhen Second People's Hospital
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of roxadustat and erythropoietin in anemia of renal disease (2 arms), sponsored by Shenzhen Second People's Hospital. Primary endpoint: Thyroid function. Started Jan 2022; status: recruiting.
02
Drugs
roxadustaterythropoietin
03
Conditions
anemia of renal disease
Beyond the preview
Go deeper on ChiCTR2100054190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054190.